Wen-Ho Chang

Original Research

Adjunctive Fluvoxamine Inhibits Clozapine-Related Weight Gain and Metabolic Disturbances

Letter to the Editor

Clozapine Versus Risperidone in Treatment-Refractory Schizophrenia: Possible Impact of Dosing Strategies

Original Research

Effects of Gender and Age on Plasma Levels of Clozapine and Its Metabolites: Analyzed by Critical Statistics

Original Research

Effects of Patient Demographics, Risperidone Dosage, and Clinical Outcome on Body Weight in Acutely Exacerbated Schizophrenia

Letter to the Editor

Elevated Plasma Clozapine Concentrations After Phenobarbital Discontinuation

Original Research

Equivalent Switching Dose From Oral Risperidone to Risperidone Long-Acting Injection: A 48-Week Randomized, Prospective, Single-Blind Pharmacokinetic Study

Original Research

Fluvoxamine Reduces the Clozapine Dosage Needed in Refractory Schizophrenic Patients

Letter to the Editor

Manic and Psychotic Symptoms Following Risperidone Withdrawal in a Schizophrenic Patient

Letter to the Editor

A Pilot Double-Blind, Dose-Comparison Study of Risperidone in Drug-Naive, First-Episode Schizophrenia

Original Research

Repeated Ingestion of Grapefruit Juice Does Not Alter Clozapine's Steady-State Plasma Levels, Effectiveness, and Tolerability

Original Research

Risperidone in Acutely Exacerbated Schizophrenia: Dosing Strategies and Plasma Levels

Letter to the Editor

Risperidone-Carbamazepine Interactions: Is Cytochrome P450 3A Involved?

Letter to the Editor

Risperidone Monotherapy for Psychotic Depression Unresponsive to Other Treatments

Letter to the Editor

Seizure During Risperidone Treatment in an Elderly Woman Treated With Concomitant Medications

Letter to the Editor

Adjunctive Fluvoxamine Inhibits Clozapine-Related Weight Gain and Metabolic Disturbances

Clozapine Versus Risperidone in Treatment-Refractory Schizophrenia: Possible Impact of Dosing Strategies

Effects of Gender and Age on Plasma Levels of Clozapine and Its Metabolites: Analyzed by Critical Statistics

Effects of Patient Demographics, Risperidone Dosage, and Clinical Outcome on Body Weight in Acutely Exacerbated Schizophrenia

Elevated Plasma Clozapine Concentrations After Phenobarbital Discontinuation

Equivalent Switching Dose From Oral Risperidone to Risperidone Long-Acting Injection: A 48-Week Randomized, Prospective, Single-Blind Pharmacokinetic Study

Fluvoxamine Reduces the Clozapine Dosage Needed in Refractory Schizophrenic Patients

Manic and Psychotic Symptoms Following Risperidone Withdrawal in a Schizophrenic Patient

A Pilot Double-Blind, Dose-Comparison Study of Risperidone in Drug-Naive, First-Episode Schizophrenia

Repeated Ingestion of Grapefruit Juice Does Not Alter Clozapine's Steady-State Plasma Levels, Effectiveness, and Tolerability

Risperidone in Acutely Exacerbated Schizophrenia: Dosing Strategies and Plasma Levels

Risperidone-Carbamazepine Interactions: Is Cytochrome P450 3A Involved?

Risperidone Monotherapy for Psychotic Depression Unresponsive to Other Treatments

Seizure During Risperidone Treatment in an Elderly Woman Treated With Concomitant Medications

Seizures After Discontinuation of Low-Dose Lorazepam From Originally Seizure-Free Clozapine Regimen: Combined Effects?

ELSEWHERE:

FOLLOW US:

Wen-Ho Chang

Adjunctive Fluvoxamine Inhibits Clozapine-Related Weight Gain and Metabolic Disturbances

Clozapine Versus Risperidone in Treatment-Refractory Schizophrenia: Possible Impact of Dosing Strategies

Effects of Gender and Age on Plasma Levels of Clozapine and Its Metabolites: Analyzed by Critical Statistics

Effects of Patient Demographics, Risperidone Dosage, and Clinical Outcome on Body Weight in Acutely Exacerbated Schizophrenia

Elevated Plasma Clozapine Concentrations After Phenobarbital Discontinuation

Equivalent Switching Dose From Oral Risperidone to Risperidone Long-Acting Injection: A 48-Week Randomized, Prospective, Single-Blind Pharmacokinetic Study

Fluvoxamine Reduces the Clozapine Dosage Needed in Refractory Schizophrenic Patients

Manic and Psychotic Symptoms Following Risperidone Withdrawal in a Schizophrenic Patient

A Pilot Double-Blind, Dose-Comparison Study of Risperidone in Drug-Naive, First-Episode Schizophrenia

Repeated Ingestion of Grapefruit Juice Does Not Alter Clozapine's Steady-State Plasma Levels, Effectiveness, and Tolerability

Risperidone in Acutely Exacerbated Schizophrenia: Dosing Strategies and Plasma Levels

Risperidone-Carbamazepine Interactions: Is Cytochrome P450 3A Involved?

Risperidone Monotherapy for Psychotic Depression Unresponsive to Other Treatments

Seizure During Risperidone Treatment in an Elderly Woman Treated With Concomitant Medications

Seizures After Discontinuation of Low-Dose Lorazepam From Originally Seizure-Free Clozapine Regimen: Combined Effects?

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles